Invitae Corp.
(NYSE : NVTA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
EVHCEnvision Healthcare Holdings, Inc.
0.14%50.288.2%$94.03m
DVADaVita HealthCare Partners Inc.
0.43%56.472.0%$85.09m
ACHCAcadia Healthcare Company, Inc.
0.57%47.1727.5%$60.89m
MDMEDNAX, Inc.
0.69%42.5610.2%$55.84m
AMEDAmedisys, Inc.
-0.02%50.2411.0%$31.59m
WOOFVCA Inc.
0.04%92.592.0%$31.38m
PMCPharMerica Corporation
-0.09%29.032.4%$22.89m
CHEChemed Corporation
0.24%188.0310.0%$20.83m
LHCGLHC Group, Inc.
-0.05%64.285.0%$12.01m
FMSFresenius Medical Care AG & Co. KGaA Sponsored ADR
-0.30%46.240.1%$9.37m
AFAMAlmost Family, Inc.
-0.10%48.903.4%$8.10m
COChina Cord Blood Corporation
1.24%13.020.6%$6.14m
ENSGEnsign Group, Inc.
0.71%19.756.1%$4.08m
USPHU.S. Physical Therapy, Inc.
1.10%59.904.8%$3.97m
NEONeoGenomics, Inc.
-0.33%9.138.0%$2.41m

Company Profile

Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It provides diagnostic service comprising approximately 1,500 genes for a variety of genetic disorders associated with oncology, cardiology, neurology, pediatrics, and whole exome analysis service. The company has created a genome network to connect patients, clinicians, advocacy organizations, researchers, and therapeutic developers to accelerate the understanding, diagnosis, and treatment of hereditary disease. Invitae was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.